Bone Metastases - Featured Article

Article

Bone Complications: An Unavoidable Side-Effect of Cancer Treatment in the Elderly?

 

Osteoprosis and osteopenia and are increasingly common in cancer patients, due both to the aging population and new forms of cancer treatment. This week we feature

Lodovico Balducci's article

on bone complications of cancer treatment in the elderly. One of ONCOLOGY's own Editors in Chief, Bill Wood from the UNC Lineberger Comprehensive Cancer Center

comments

, and Drs Cohen and Naeim from the David Geffen School of Medicine also share their

viewpoint 

on this topic of increasing importance.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
5 experts are featured in this series
5 experts are featured in this series
2 experts in this video
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.
2 experts in this video
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Related Content